158 related articles for article (PubMed ID: 37273485)
1. Multi-Omics Analysis and Verification of the Oncogenic Value of CCT8 in Pan-Cancers.
Gong L; Zhong M; Gong K; Wang Z; Zhong Y; Jin Y; Chen H; Tai P; Chen X; Chen A; Cao K
J Inflamm Res; 2023; 16():2297-2315. PubMed ID: 37273485
[TBL] [Abstract][Full Text] [Related]
2. Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas.
Wei C; Wang B; Peng D; Zhang X; Li Z; Luo L; He Y; Liang H; Du X; Li S; Zhang S; Zhang Z; Han L; Zhang J
Front Immunol; 2022; 13():849592. PubMed ID: 35444654
[TBL] [Abstract][Full Text] [Related]
3. Integrated pan-cancer analysis and experimental verification of the roles of tropomyosin 4 in gastric cancer.
Guo Q; Zhao L; Yan N; Li Y; Guo C; Dang S; Shen X; Han J; Luo Y
Front Immunol; 2023; 14():1148056. PubMed ID: 36993958
[TBL] [Abstract][Full Text] [Related]
4. Pan-cancer analysis reveals NAA50 as a cancer prognosis and immune infiltration-related biomarker.
Fang T; Wang D; Li R; Yu W; Tian H
Front Genet; 2022; 13():1035337. PubMed ID: 36568377
[No Abstract] [Full Text] [Related]
5. Pan-cancer analysis of
Jia B; Liu J; Hu X; Xia L; Han Y
Ann Transl Med; 2022 Dec; 10(24):1355. PubMed ID: 36660720
[TBL] [Abstract][Full Text] [Related]
6. A potential immunotherapeutic and prognostic biomarker for multiple tumors including glioma: SHOX2.
Wu X; Chen H; You C; Peng Z
Hereditas; 2023 May; 160(1):21. PubMed ID: 37170390
[TBL] [Abstract][Full Text] [Related]
7. Chaperonin containing TCP1, subunit 8 (CCT8) is upregulated in hepatocellular carcinoma and promotes HCC proliferation.
Huang X; Wang X; Cheng C; Cai J; He S; Wang H; Liu F; Zhu C; Ding Z; Huang X; Zhang T; Zhang Y
APMIS; 2014 Nov; 122(11):1070-9. PubMed ID: 24862099
[TBL] [Abstract][Full Text] [Related]
8. Pan-cancer analysis identifies LMNB1 as a target to redress Th1/Th2 imbalance and enhance PARP inhibitor response in human cancers.
Qin H; Lu Y; Du L; Shi J; Yin H; Jiang B; Chen W; Diao W; Ding M; Cao W; Qiu X; Zhao X; Guo H
Cancer Cell Int; 2022 Mar; 22(1):101. PubMed ID: 35241075
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic role of copper‑induced cell death‑associated protein DLD in human cancer: A pan‑cancer analysis and experimental verification.
Qi H; Zhu D
Oncol Lett; 2023 May; 25(5):214. PubMed ID: 37123026
[TBL] [Abstract][Full Text] [Related]
10. FAIM2 is a potential pan-cancer biomarker for prognosis and immune infiltration.
Cai J; Ye Z; Hu Y; Wang Y; Ye L; Gao L; Sun Q; Tong S; Sun Z; Yang J; Chen Q
Front Oncol; 2022; 12():998336. PubMed ID: 36185230
[TBL] [Abstract][Full Text] [Related]
11. NALCN is a potential biomarker and therapeutic target in human cancers.
He J; Xu J; Chang Z; Yan J; Zhang L; Qin Y
Front Genet; 2023; 14():1164707. PubMed ID: 37152978
[No Abstract] [Full Text] [Related]
12. Pan-cancer analysis combined with experiments predicts CTHRC1 as a therapeutic target for human cancers.
Peng D; Wei C; Zhang X; Li S; Liang H; Zheng X; Jiang S; Han L
Cancer Cell Int; 2021 Oct; 21(1):566. PubMed ID: 34702252
[TBL] [Abstract][Full Text] [Related]
13. CCT8 recovers WTp53-suppressed cell cycle evolution and EMT to promote colorectal cancer progression.
Liao Q; Ren Y; Yang Y; Zhu X; Zhi Y; Zhang Y; Chen Y; Ding Y; Zhao L
Oncogenesis; 2021 Dec; 10(12):84. PubMed ID: 34862361
[TBL] [Abstract][Full Text] [Related]
14. CCNE1 is a predictive and immunotherapeutic indicator in various cancers including UCEC: a pan-cancer analysis.
Zheng X; Chen L; Liu W; Zhao S; Yan Y; Zhao J; Tian W; Wang Y
Hereditas; 2023 Mar; 160(1):13. PubMed ID: 36964635
[TBL] [Abstract][Full Text] [Related]
15. Pan-cancer analysis reveals DDX21 as a potential biomarker for the prognosis of multiple tumor types.
Hu A; Wang Y; Tian J; Chen Z; Chen R; Han X; Chen Y; Liu T; Chen Q
Front Oncol; 2022; 12():947054. PubMed ID: 36505822
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of CCT8 and its significance for tumor cell proliferation, migration and invasion in glioma.
Qiu X; He X; Huang Q; Liu X; Sun G; Guo J; Yuan D; Yang L; Ban N; Fan S; Tao T; Wang D
Pathol Res Pract; 2015 Oct; 211(10):717-25. PubMed ID: 26304164
[TBL] [Abstract][Full Text] [Related]
17. NOP2/Sun RNA methyltransferase 2 is a potential pan-cancer prognostic biomarker and is related to immunity.
Zheng L; Li M; Wei J; Chen S; Xue C; Duan Y; Tang F; Li G; Xiong W; She K; Deng H; Zhou M
PLoS One; 2023; 18(9):e0292212. PubMed ID: 37769000
[TBL] [Abstract][Full Text] [Related]
18. A Comprehensive Pan-Cancer Analysis of the Tumorigenic Role of Matrix Metallopeptidase 7 (MMP7) Across Human Cancers.
Meng N; Li Y; Jiang P; Bu X; Ding J; Wang Y; Zhou X; Yu F; Zhang Y; Zhang J; Xia L
Front Oncol; 2022; 12():916907. PubMed ID: 35785154
[TBL] [Abstract][Full Text] [Related]
19. NcRNA-Mediated High Expression of
Jiang X; Tang L; Yuan Y; Wang J; Zhang D; Qian K; Cho WC; Duan L
Front Oncol; 2022; 12():846536. PubMed ID: 35311097
[TBL] [Abstract][Full Text] [Related]
20. CCT8 promotes cell migration and tumor metastasis in lung adenocarcinomas.
Wu Z; Deng L; Tao J; Lu Y; Zeng X; Jia W; Chen H
J Cancer; 2023; 14(17):3238-3247. PubMed ID: 37928427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
